Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1999
12/02/1999WO1999061448A1 Naphthosulfamylmethyl penem antibacterials
12/02/1999WO1999061446A1 G-csf mimetics
12/02/1999WO1999061445A1 G-csf mimetics
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061439A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/02/1999WO1999061438A1 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
12/02/1999WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061420A1 3-[(1--n-methylamino)ethyl-n-benzyl] pyrrolidine monomethanesulfonate
12/02/1999WO1999061097A2 Alpha emitting constructs and uses thereof
12/02/1999WO1999061064A1 Mammalian genes encoding 3'-5' exonuclease
12/02/1999WO1999061056A2 Methods and products for inducing mucosal immunity
12/02/1999WO1999061053A1 Combination meningitidis b/c vaccines
12/02/1999WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999WO1999061050A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA)
12/02/1999WO1999061049A2 Model for infection by a pathogen using administration of nucleic acids
12/02/1999WO1999061048A1 CORRELATIVE PROTECTION USING OspA ANTIBODY TITERS
12/02/1999WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999WO1999061026A1 Efavirenz compressed tablet formulation
12/02/1999WO1999061003A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999WO1999061002A1 Enteric coated pharmaceutical composition and method of manufacturing
12/02/1999WO1999061001A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
12/02/1999WO1999060999A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
12/02/1999WO1999060998A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
12/02/1999WO1999060859A1 Disinfectant composition
12/02/1999WO1999060855A1 Novel nucleosides having bicyclic sugar moiety
12/02/1999WO1999051212A3 Device for the transdermal delivery of diclofenac
12/02/1999WO1999047501A3 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection
12/02/1999WO1999047173A3 Carrier for in vivo delivery of a therapeutic agent
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999CA2333667A1 Murd protein and gene of pseudomonas aeruginosa
12/02/1999CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999CA2333380A1 Novel nucleosides having bicyclic sugar moiety
12/02/1999CA2333167A1 Method for purification of borrelia lipoprotein ospa
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2333023A1 Naphthosulfamylmethyl penem antibacterials
12/02/1999CA2332979A1 Correlative protection using ospa antibody titers
12/02/1999CA2332963A1 Combination meningitidis b/c vaccines
12/02/1999CA2332932A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/02/1999CA2332928A1 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
12/02/1999CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332371A1 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract
12/02/1999CA2332369A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999CA2332318A1 G-csf mimetics
12/02/1999CA2332317A1 G-csf mimetics
12/02/1999CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999CA2329155A1 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/02/1999CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2328894A1 Methods and products for inducing mucosal immunity
12/02/1999CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999CA2298982A1 Disinfectant composition
12/01/1999EP0960204A1 Method and reagents for genetic immunization
12/01/1999EP0960191A1 Compositions and methods for use of defensin
12/01/1999EP0960122A1 Myelopeptides and their therapeutic use
12/01/1999EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999EP0960103A1 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)
12/01/1999EP0960098A1 Arylsulfonyl hydroxamic acid derivatives
12/01/1999EP0959903A1 NOVEL FabD
12/01/1999EP0959901A1 A method for generating birnavirus from synthetic rna transcripts
12/01/1999EP0959898A1 Lactoferrin variants and uses thereof
12/01/1999EP0959895A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
12/01/1999EP0959883A1 Inhibitors of farnesyl-protein transferase
12/01/1999EP0959881A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
12/01/1999EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999CN1237183A 6-0-substituted ketolides having antibacterial activity
12/01/1999CN1237178A Novel 'beta'-lactam compounds and process for preparing the same
12/01/1999CN1237175A 2R, 4S, S, S- and 2S, 4R, S, S-hydroxyitraconazole
12/01/1999CN1237174A 2R, 4S, S, R- and 2S, 4R, S, R-hydroxyitraconazole
12/01/1999CN1237173A 2R, 4S, R, R- and 2S, 4R, R, R-hydroxyitraconazole
12/01/1999CN1237172A 2R, 4S, R, S- and 2S, 4R, R, S-hydroxyitraconazole and hydroxysaperconazole
12/01/1999CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999CN1237102A Liposomes
12/01/1999CN1236616A Application of benzimidazole derivatives in preparing medicine
11/1999
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994500 Antagonists of intestinotrophic GLP-2 peptides
11/30/1999US5994409 Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
11/30/1999US5994400 Reducing ph of aqueous solution; collecting precipitate; solubilizing
11/30/1999US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999US5994343 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
11/30/1999US5994340 Synergistic mixture with antibiotics
11/30/1999US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999US5994312 Peptidyl compounds
11/30/1999US5994308 Bactericides; fungicides
11/30/1999US5994307 Human t-cell lymphoma virus
11/30/1999US5994306 Fine-tuned protegrins
11/30/1999US5994299 Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them
11/30/1999US5994297 Therapy for Staphylococcus aureus
11/30/1999US5994293 Peptidyl compounds and their therapeutic use
11/30/1999US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999US5994116 Preparing a non-infectious viral particle having defects in its replication proteins; infecting cells with the virus and a chemical inhibitor of dna synthesis, preventing viral replication and recovering the desired particles; vaccines
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994101 DNA encoding gidA1 polypeptides
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994096 Regulator
11/30/1999US5994055 HIV trans-activator Tat binding to CDK7 and activation of CTD phosphorylation
11/30/1999US5993856 Pharmaceutical preparations and methods for their administration
1 ... 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 ... 1798